Vertex Pharmaceuticals VRTX Return on invested capital

Return on invested capital at other companies

Lexicon PharmaceuticalsLXRX

-13.5%-6.1pp

Travere Therapeutics, Inc.TVTX

-118%-48.4pp

Agios PharmaceuticalsAGIO

-40%-5.0pp

AbbVieABBV

17.1%—

4D Molecular TherapeuticsFDMT

-51.1%-5.5pp

Beam TherapeuticsBEAM

-39.4%-8.8pp

FAQ

What is Vertex Pharmaceuticals's return on invested capital?

Vertex Pharmaceuticals (VRTX) reported return on invested capital of 28.4% in Q2 2026.

How has Vertex Pharmaceuticals's return on invested capital changed year-over-year?

Vertex Pharmaceuticals's return on invested capital increased by 5.1% year-over-year, from 27% to 28.4%.

What is the long-term trend for Vertex Pharmaceuticals's return on invested capital?

Over 5 years (2020 to 2025), Vertex Pharmaceuticals's return on invested capital has grown at a -11.2% compound annual growth rate (CAGR), from 44% to 24.3%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.